GSR Invests $100M in MEI Pharma to Launch Litecoin Treasury Strategy

GSR has announced a $100 million private investment in MEI Pharma (NASDAQ: MEIP) and a new strategic partnership. As part of the agreement, GSR will serve as a strategic advisor and manage MEI’s digital asset treasury. This move signals a new direction for MEI, which plans to adopt Litecoin (LTC) as a core treasury asset.

Charlie Lee, the creator of Litecoin, and a GSR representative will join MEI’s Board of Directors. The Litecoin Foundation will support the initiative. This development follows MEI’s earlier review of strategic alternatives and shows its transition toward a digital asset-focused business model.

GSR will help MEI manage its Litecoin holdings and support the company’s operations within the digital asset space. The partnership is designed to connect public markets with crypto strategies, and MEI’s leadership is working to align its new direction with the goals of both GSR and the Litecoin Foundation.

The investment also includes participation from several crypto-focused investment firms and infrastructure providers. GSR, which has supported other blockchain projects including those on the Polygon network, continues to provide liquidity, and advisory services across the digital asset industry.

Image: Freepik